1. Home
  2. CTKB vs PDT Comparison

CTKB vs PDT Comparison

Compare CTKB & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

SELL

Current Price

$5.25

Market Cap

541.1M

Sector

Health Care

ML Signal

SELL

Logo John Hancock Premium Dividend Fund

PDT

John Hancock Premium Dividend Fund

SELL

Current Price

$11.90

Market Cap

618.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
CTKB
PDT
Founded
1990
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
541.1M
618.8M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
CTKB
PDT
Price
$5.25
$11.90
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $5.56
N/A
AVG Volume (30 Days)
★ 1.6M
151.3K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $193,015,000.00
N/A
Revenue This Year
$3.94
N/A
Revenue Next Year
$6.59
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 17.67
N/A
52 Week Low
$3.31
$11.56
52 Week High
$6.21
$13.65

Technical Indicators

Market Signals
Indicator
CTKB
PDT
Relative Strength Index (RSI) 46.52 45.43
Support Level $4.17 N/A
Resistance Level $5.29 $12.08
Average True Range (ATR) 0.29 0.16
MACD -0.08 0.03
Stochastic Oscillator 15.45 60.54

Price Performance

Historical Comparison
CTKB
PDT

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About PDT John Hancock Premium Dividend Fund

John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.

Share on Social Networks: